$250.00
55.5mg Total Combination (Dihexa / Tesofensine / Methylene Blue) – Oral Capsules
Nerium Blue Capsules 55.5mg is an ultimate-tier, high-purity oral formulation pairing the neurogenic power of Dihexa, the triple monoamine reuptake inhibition of Tesofensine, and the cellular bioenergetics of Methylene Blue. By concurrently upregulating the HGF/c-Met pathway for spinogenesis, blocking presynaptic neurotransmitter reuptake for central satiety, and cycling mitochondrial electrons to maximize ATP synthesis, this precisely standardized 55.5mg capsule presentation stands as a premier investigative tool for tracking advanced lipid beta-oxidation, down-regulated food-seeking behaviors, prefrontal focus dynamics, and tissue-level oxidative stress mitigation in laboratory models.
Supplied as stable, precisely standardized 55.5mg research capsules. Restricted strictly to laboratory and in vitro evaluation.
Eterna Peptides presents premium-grade Nerium Blue Capsules (55.5mg), an ultimate-tier oral research formulation engineered to study profound neuro-regeneration, triple monoamine reuptake inhibition, and mitochondrial bioenergetic optimization. Combining three high-purity, structurally distinct compounds—the pioneering neurogenic peptide analogue Dihexa, the potent metabolic regulator Tesofensine, and the classic electron cycler Methylene Blue—inside a single precisely standardized 55.5mg capsule, this synergistic matrix serves as the definitive investigative tool for tracking advanced synaptic plasticity, central satiety activation, and cellular ATP upregulation.
### Advanced 55.5mg Synergistic Compound Profile
Each carefully calibrated oral capsule delivers a precise structural distribution of targeted research molecules:
* **Dihexa (Heptanoic-Tyr-Ile-hexanoate amide):** An oligopeptide variant derived from angiotensin IV that exhibits ultra-high affinity for Hepatocyte Growth Factor ($HGF$). It is intensively investigated for its capacity to induce high-velocity spinogenesis and dendritic arborization, reinforcing synaptic connectivity.
* **Tesofensine (NS2330):** A potent triple monoamine reuptake inhibitor (TRI) that blocks the presynaptic transporters for Dopamine, Norepinephrine, and Serotonin. This action elevates synaptic neurotransmitter concentrations, serving as a premier model for tracking central appetite down-regulation and elevated resting metabolic expenditure.
* **Methylene Blue (Methylthioninium Chloride):** A high-affinity redox cycler that easily crosses blood-brain barrier boundaries. It acts as an artificial electron mediator within the mitochondrial respiratory chain, optimizing oxygen consumption rates and mitigating intracellular oxidative stress.
### Mechanism of Action
The Nerium Blue matrix targets complementary neurological and metabolic checkpoints to explore advanced cellular signaling and bioenergetics:
* **HGF/c-Met Pathway & Spinogenesis:** Dihexa binds directly to HGF, potentiating its signaling through the c-Met receptor tyrosine kinase network. This cascade enhances long-term potentiation ($LTP$) and promotes the formation of new functional synaptic connections, allowing researchers to track accelerated cognitive longevity and memory consolidation pathways.
* **Triple Monoamine Modulation & Satiety:** Tesofensine increases synaptic availability of norepinephrine and serotonin to trigger powerful central satiety cascades. Concurrently, its inhibition of dopamine reuptake reinforces reward-motivated pathways, allowing for the comprehensive mapping of attenuated food-seeking behaviors and enhanced prefrontal focus metrics.
* **Mitochondrial Electron Shifting & ATP Maximization:** Methylene Blue skips traditional blocks in the electron transport chain by cycling electrons directly between $NADH$ dehydrogenase (Complex I) and Cytochrome c (Complex III/IV). This biochemical bypass maximizes Adenosine Triphosphate ($ATP$) synthesis efficiency while drastically reducing electron leakage and the formation of destructive reactive oxygen species ($ROS$).
* **Sympathetic Outflow & Lipid Beta-Oxidation:** Via central noradrenergic pathways, the combination triggers an upregulation of sympathetic outflow. This cascade is tracked for its direct impact on increasing resting metabolic rate, accelerating lipid oxidation ($ \beta\text{-oxidation} $), and inducing white adipose tissue energy expenditure.
### Research Applications
In preclinical and in vitro laboratory models, Nerium Blue Capsules 55.5mg are actively utilized to investigate:
* Prefrontal cortex synaptic plasticity, dendritic spine density growth, and neurodegenerative resilience modeling.
* High-velocity lipid mobilization, white adipose tissue repartitioning, and resting metabolic rate adaptation.
* Central nervous system satiety signaling, arcuate nucleus neurochemistry, and behavioral food-reward attenuation.
* Mitochondrial respiratory chain efficiency, cardiolipidic protection, and cellular longevity signaling curves.
Our Nerium Blue Capsules are precision-manufactured under strict laboratory quality control guidelines to ensure absolute ingredient standardization, high chemical purity, and dependable experimental reproducibility across every research batch.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
